Sustained Weight Loss With Controlled-Release Phentermine/Topiramate May ... - Medical News Today

Thank you for using rssforward.com! This service has been made possible by all our customers. In order to provide a sustainable, best of the breed RSS to Email experience, we've chosen to keep this as a paid subscription service. If you are satisfied with your free trial, please sign-up today. Subscriptions without a plan would soon be removed. Thank you!
Editor's Choice
Main Category: Diabetes
Also Included In: Endocrinology
Article Date: 20 Sep 2011 - 7:00 PDT email icon email to a friend   printer icon printer friendly   write icon opinions  

Long-term weight loss with controlled-release phentermine/topiramate appears to reverse metabolic syndrome and improve associated traits, according to results released at the 47th European Society for the Study of Diabetes (EASD) Annual Meeting.

Hermann Toplak, MD, Medical University of Graz in Graz, Austria, and colleagues evaluated the long-term effects of controlled-release phentermine/topiramate as an adjunct to lifestyle intervention on weight loss and the metabolic syndrome over 108 weeks.

The study population included patients with metabolic syndrome at baseline in the CONQUER study. In the 56-week CONQUER study, low-dose, controlled-release phentermine/topiramate, when added to lifestyle interventions, demonstrated significant weight loss and resolution of metabolic syndrome.

Dr. Toplak pointed out that the incidence of metabolic syndrome has been increasing worldwide, probably as a result of the increased rate of obesity. Both metabolic syndrome and obesity are risk factors for type 2 diabetes.

Weight loss has been proposed as the first-line intervention for metabolic syndrome and its associated components, he said.

Results of the present analysis showed that in patients who had metabolic syndrome but not type 2 diabetes at baseline, weight loss was significantly greater with controlled-release phentermine/topiramate than with placebo. Also, weight loss was maintained over 108 weeks.

More than twice as many patients treated with controlled-release phentermine/topiramate had resolution of metabolic syndrome versus placebo. In addition, fewer patients without metabolic syndrome at baseline progressed to metabolic syndrome with controlled-release phentermine/topiramate than placebo.

In this population of patients with metabolic syndrome at baseline, controlled-release phentermine/topiramate produced larger reductions in fasting blood glucose and insulin than placebo, which indicates an increase in insulin sensitivity. The active drug was also associated with decreases in waist circumference, blood pressure, and triglycerides, and increases in high-density lipoprotein (HDL)-cholesterol.

Controlled-release phentermine/topiramate was generally well tolerated.

Dr. Toplak said that the results suggest that controlled-release phentermine/ topiramate on top of lifestyle intervention may be useful for combating both the obesity epidemic and the underlying pathophysiology that leads to the progression of cardiometabolic disease.

Written by Jill Stein
Jill Stein is a Paris-based freelance medical writer.
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our  diabetes section for the latest news on this subject.

47th European Society for the Study of Diabetes (EASD) Annual Meeting

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Jill Stein. "Sustained Weight Loss With Controlled-Release Phentermine/Topiramate May Improve Metabolic Syndrome Traits." Medical News Today. MediLexicon, Intl., 20 Sep. 2011. Web.
20 Sep. 2011. <http://www.medicalnewstoday.com/articles/234704.php>


APA

Please note: If no author information is provided, the source is cited instead.


Rate this article:
(Hover over the stars then click to rate)
Patient / Public:
or Health Professional:

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


20 Sep, 2011


--
Source: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE2kZmjolXvnLdWTv49wAYvoaJ2Mw&url=http://www.medicalnewstoday.com/articles/234704.php
~
Manage subscription | Powered by rssforward.com

8 Responses to “Beauty Skin Care Natural”

What's on Your Mind...

Powered by Blogger.